Director, Global Forecasting and Insights- Oncology at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must possess business leadership experience and a proven track record of influencing without authority, successfully resolving conflicts, and driving consensus with senior cross-functional partners. Strong leadership acumen demonstrated through relationships with stakeholders, peers, and teams is required, along with experience presenting to senior leadership and simplifying complex quantitative data. Experience working in a matrixed organization, partnering with global Sales and Marketing organizations, and familiarity with pharmaceutical data sources are also necessary.

Responsibilities

The Director, Global Forecasting and Insights will partner with leadership to define global market research priorities and lead qualitative and quantitative primary research with physicians, patients, and payers. Responsibilities include analyzing secondary data sources to produce summaries and insights, developing and maintaining long-term forecast models for key products and indications, and collaborating with various internal teams to ensure quality data assumptions in forecasting models. The role involves conducting scenario modeling, managing quantitative market research execution, and effectively communicating complex quantitative data to inform business decisions.

Skills

Forecasting

Market Research

Qualitative Research

Quantitative Research

Data Analysis

Insights Generation

Breast Cancer

Oncology

Leadership

Strategic Marketing

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free